- Home
- NSTS vs LTRN Comparison
NSTS vs LTRN Comparison
Compare NSTS & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- LTRN
- Stock Information
- Founded
- NSTS 1921
- LTRN 2013
- Country
- NSTS United States
- LTRN United States
- Employees
- NSTS N/A
- LTRN N/A
- Industry
- NSTS Savings Institutions
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- LTRN Health Care
- Exchange
- NSTS Nasdaq
- LTRN Nasdaq
- Market Cap
- NSTS 58.7M
- LTRN 49.9M
- IPO Year
- NSTS N/A
- LTRN 2020
- Fundamental
- Price
- NSTS $11.15
- LTRN $3.72
- Analyst Decision
- NSTS
- LTRN Strong Buy
- Analyst Count
- NSTS 0
- LTRN 1
- Target Price
- NSTS N/A
- LTRN $25.00
- AVG Volume (30 Days)
- NSTS 6.5K
- LTRN 72.4K
- Earning Date
- NSTS 11-13-2025
- LTRN 11-12-2025
- Dividend Yield
- NSTS N/A
- LTRN N/A
- EPS Growth
- NSTS N/A
- LTRN N/A
- EPS
- NSTS N/A
- LTRN N/A
- Revenue
- NSTS $9,762,000.00
- LTRN N/A
- Revenue This Year
- NSTS N/A
- LTRN N/A
- Revenue Next Year
- NSTS N/A
- LTRN N/A
- P/E Ratio
- NSTS N/A
- LTRN N/A
- Revenue Growth
- NSTS 57.78
- LTRN N/A
- 52 Week Low
- NSTS $10.72
- LTRN $2.55
- 52 Week High
- NSTS $13.32
- LTRN $6.12
- Technical
- Relative Strength Index (RSI)
- NSTS 51.22
- LTRN 49.75
- Support Level
- NSTS $11.12
- LTRN $2.86
- Resistance Level
- NSTS $11.24
- LTRN $3.93
- Average True Range (ATR)
- NSTS 0.06
- LTRN 0.27
- MACD
- NSTS 0.04
- LTRN 0.06
- Stochastic Oscillator
- NSTS 69.70
- LTRN 70.09
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.